🚀 Exciting news! #ODSS just dropped a Research Opportunity Announcement for their Advancing #HealthResearch through Ethical, Multimodal AI Initiative! Dive in to support the creation of ethical, data-driven, multimodal #AI. Learn more: bit.ly/4af46MC

Just published for today's #AACR24 Plenary Session: #ArtificialIntelligence in Oncology— Current Landscape, Challenges, and Future Directions, a review by Ethan Cerami et al. bit.ly/3TWeXUT Dana-Farber Dana-Farber Data Science

NIH is giving away cloud compute. Students and postdocs take note!

Congratulations to these talented trainees! It was wonderful to see so many early career scientists excel in presenting their research. #NCIITCR

Artificial Intelligence (AI) has the potential to transform everything we do in #CancerResearch. For instance, #AI is helping to improve the speed, accuracy, and reliability of some cancer screening and detection methods. Dive in 🏊🏼‍♀️ for more. go.nih.gov/AQUf8ep

Survey to Assess the Needs for Compute-Intensive Resources in the Cancer Research Community The National Cancer Institute CBIIT is conducting a survey to assess the compute-intensive resource needs of the cancer research community. ncidccpssurveys.gov1.qualtrics.com/jfe/form/SV_1N…

NLM’s #ClinVar streamlines genomic data access to empower clinicians with crucial insights for cancer diagnosis, patient care & treatment outcomes. Its most recent update better supports #SomaticVariants! 🧬 Today’s #NLMMusings shares more + how to submit: loom.ly/wlZaghA

Moderated by Carey Goldberg (carey goldberg), session 1 of our next event features real-life reports of AI in health care from Hugo de O. Campos, Grace Cordovano, PhD, BCPA (Enlightening Results 💡) & Jorge Rodriguez, MD (Jorge A Rodriguez MD). Save your spot: nejm.ai/4743Orc

Thrilled to drop new perspective Cancer Discovery "New Era of Data-Driven Cancer Research & Care" with Felicia Gomez Pallavi Tiwari Spyridon Bakas Christos Davatzikos @ElanaFertig Jayashree Kalpathy @JohannaKenney Eli Van Allen @FredPrior Malachi Griffith Obi Griffith, PhD URL: tinyurl.com/yfk5549f

MCC's Dr. Jill Mesirov is a senior author in the October Cancer Discovery issue, for her research on transforming cancer research through informatics.🎗️ Discover how software tools for cancer research are essential to the entire field: bit.ly/4gThv0z. 🔬

.NIH funding alert: New opportunity to support exceptional Research Software Engineers in biomedical, behavioral, and health fields. Offers salary support for developing and disseminating software tools, plus training users. First deadline: Dec 4, 2024 bit.ly/3xZnDmx

Science in Society: A new era of data-driven cancer research and care: opportunities and challenges – by Felicia Gomez, Arpad Danos, Malachi Griffith, Obi Griffith, PhD, and colleagues @WUDeptMedicine bit.ly/3BUmI8e

In Focus: Transforming cancer research through informatics – by Juli Klemm, Dinah Singer, and Jill Mesirov @NCI_CSSI National Cancer Institute UC San Diego Health Moores Cancer Center bit.ly/3A11ULQ

A huge day for spatial omics of cancer, tracing the precise origin and evolution of 20 types of cancer, many in 3D, in ~2,000 individuals, with 12 publications nature Nature Cancer Nature Medicine Nature Methods Communications Biology Collection nature.com/immersive/d428…

Check out this amazing new tutorial that shows how you can use Galaxy Project to create, train, and test deep learning models in your web browser! There's so much you can do with machine learning in Galaxy these days. We'll be sharing more tutorials and examples very soon

The 1st real world multimodal, integrated, automated data resource of ~25,000 cancer patients — with NLP of structured and unstructured EHR text, genomics, radiology reports -> Improved prediction for patient outcomes Memorial Sloan Kettering Cancer Center Niki Schultz and colleagues nature

🗝️The right drug molecule will bind to a protein to treat a disease. But what about "undruggable targets"? #JClinic PIs Regina Barzilay & Marzyeh co-authored a new paper in Nature Biotechnology w/ 15 co-authors on how AI could challenge drug design. nature.com/articles/s4158…